News

A New Design Strategy in Nanomedicine Improves Antitumor Efficacy While Reducing Drug Dose

Reducing chemotherapy toxicity without compromising efficacy remains one of the major challenges in oncology. A research team from the Institut de Recerca Sant Pau (IR Sant Pau) has shown in a study p...

A Juan de la Cierva Grant Strengthens Research in Functional Genomics of Cancer and Rare Diseases at IR Sant Pau

The Agencia Estatal de Investigación (AEI) has awarded a Juan de la Cierva grant to Dr. Gerard Muñoz Pujol. He will carry out his scientific activity at the Sant Pau Research Institute (IR Sant Pau)...

IR Sant Pau Investigates Rare Diseases to Transform Diagnosis and Treatment

Rare diseases pose one of the greatest challenges for current biomedical research. Their low individual prevalence, clinical heterogeneity, and underlying molecular complexity hinder early diagnosis a...

IR Sant Pau Advances the Development of Fanconinib, a Pioneering Inhibitor Targeting a Key Cancer Pathway

The Sant Pau Research Institute (IR Sant Pau) has received funding from the national “Proof of Concept Projects 2025” call, promoted by the Ministry of Science, Innovation, and Universities throug...

Preeclampsia Leaves a Lasting Mark on the Cardiovascular System Years After Pregnancy, Even in the Absence of Apparent Symptoms

Preeclampsia is a pregnancy complication widely known for its immediate impact on maternal and fetal health. However, scientific evidence accumulated recently has shown that preeclampsia is also assoc...